PTGS2 and gastric cancer: Through clinical trials and in vitro experiments, Lin et al. [15] further confirmed that COX-2 was a downstream gene induced by Cyr-61, and Cyr-61 could affect the invasion ability of gastric cancer cells by upregulating COX-2 activity via the αVβ3/NF-kB pathway.